CX3CL1 and cancer: Relevantly, clinical samples exhibited a negative correlation between miR-561-5p expression and levels of CX3CL1 and CX3CR1+ in NK cells, cells that exhibit a relevant antitumor response 38, suggesting that CX3CL1 could have clinical relevance in cancer.